# Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)

Study · id `cardio:ct-nct01296412` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01296412](<https://clinicaltrials.gov/study/NCT01296412>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01296412

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 653 participants.

## Technical summary

Registry record NCT01296412. Randomized; no masking; primary purpose treatment. Start 2011-03-11 (actual); primary completion 2012-02-29 (actual). Results posted on 2013-03-15.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 653 participants (enrolled count; ClinicalTrials.gov record NCT01296412, source copy `cardio:ctgov-nct01296412-2017-06-09`, retrieved 2026-10-26)
- Started: 2011-03-11 (actual) (ClinicalTrials.gov record NCT01296412, source copy `cardio:ctgov-nct01296412-2017-06-09`, retrieved 2026-10-26)
- Primary completion: 2012-02-29 (actual) (ClinicalTrials.gov record NCT01296412, source copy `cardio:ctgov-nct01296412-2017-06-09`, retrieved 2026-10-26)
- Completion: 2012-02-29 (actual) (ClinicalTrials.gov record NCT01296412, source copy `cardio:ctgov-nct01296412-2017-06-09`, retrieved 2026-10-26)
- Results first posted: 2013-03-15 (ClinicalTrials.gov record NCT01296412, source copy `cardio:ctgov-nct01296412-2017-06-09`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01296412-2017-06-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): sitagliptin
- Intervention (Drug): liraglutide
- Intervention (Drug): glimepiride
- Intervention (Drug): metformin
- Lead sponsor: Merck Sharp & Dohme LLC
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Merck Sharp & Dohme LLC (`cardio:org-merck-sharp-dohme-llc`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial (`cardio:pubmed-23604551`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 51c5fb1b8b01e8143f68f924915e2a7499a4582c93ee95f03b075c40aadb1765
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
